Verition Fund Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38M | Buy |
148,602
+78,172
| +111% | +$725K | 0.01% | 1661 |
|
|
2025
Q1 | $516K | Buy |
+70,430
| New | +$516K | ﹤0.01% | 1973 |
|
|
2024
Q4 | – | Sell |
-62,501
| Closed | -$544K | – | 2718 |
|
|
2024
Q3 | $544K | Buy |
+62,501
| New | +$544K | ﹤0.01% | 1642 |
|
|
2023
Q3 | – | Sell |
-54,950
| Closed | -$284K | – | 2182 |
|
|
2023
Q2 | $284K | Buy |
+54,950
| New | +$284K | ﹤0.01% | 1373 |
|
|
2023
Q1 | – | Sell |
-17,502
| Closed | -$49.2K | – | 2106 |
|
|
2022
Q4 | $49.2K | Buy |
17,502
+7,273
| +71% | +$20.4K | ﹤0.01% | 1481 |
|
|
2022
Q3 | $42K | Hold |
10,229
| – | – | ﹤0.01% | 2094 |
|
|
2022
Q2 | $41K | Buy |
10,229
+229
| +2% | +$918 | ﹤0.01% | 2083 |
|
|
2022
Q1 | $50K | Hold |
10,000
| – | – | ﹤0.01% | 1695 |
|
|
2021
Q4 | $70K | Buy |
+10,000
| New | +$70K | ﹤0.01% | 1679 |
|